This inventor holds 3 USPTO granted patents. Top assignee: Boehringer Mannheim Gmbh. Active years: 1995-1997.
Company Filing History:
Years Active: 1995-1997
Title: Innovations of Geoffrey Burns in Biochemistry
Introduction
Geoffrey Burns is a notable inventor based in Munich, Germany. He has made significant contributions to the field of biochemistry, particularly in the development of peptide antigens. With a total of 3 patents, his work has implications for both medical research and therapeutic applications.
Latest Patents
Burns' latest patents include the invention of Streptolysin O peptide antigens and methods for the determination of SLO peptide antigens. These peptide antigens are designed for the determination of SLO antibodies, serving as immunogens for the production of antibodies against SLO, and as vaccines for the production of vaccines against SLO. Another significant patent involves lipoprotein (a) peptides, which have a partial sequence of lipoprotein (a) and are utilized for the purification of antibodies through affinity chromatography. These peptides also serve as immunogens for antibody production and as standards in immunological tests or competitive haptens in agglutination tests.
Career Highlights
Geoffrey Burns is associated with Boehringer Mannheim GmbH, where he has been able to apply his innovative ideas in a collaborative environment. His work has not only advanced scientific understanding but has also paved the way for new therapeutic strategies.
Collaborations
Some of his notable coworkers include Christoph Seidel and Wolf-Dieter Engel, who have contributed to the collaborative efforts in their research endeavors.
Conclusion
Geoffrey Burns exemplifies the spirit of innovation in biochemistry through his patents and contributions to the field. His work continues to influence the development of new medical technologies and therapeutic solutions.